彰化商業銀行股份有限公司受託保管新光全球生技醫療證券投資信託基金專戶

2549007LB0S56Y7VLO54

The entity

Status: Active
LEI status: Issued and current
Category: Fund
Legal form: 8888
Jurisdiction: Taiwan
Entity created: October 9, 2014

Address

Country: Taiwan
Legal address: 9F. & 11F., No.167, Sec. 2, Nanjing E. Rd, Zhongshan Dist.104475 TaipeiTaiwan (TW-TPE)
Head office: C/O Taishin Securities Investment Trust Company Limited, 1 F., No. 9-1, Dehui St., Zhongshan Dist104439 TaipeiTaiwan (TW-TPE)

Identifier

LEI: 2549007LB0S56Y7VLO54
Registered: October 27, 2017 at 01:08 PM UTC
Last updated: December 19, 2025 at 05:58 PM UTC
Next renewal: October 18, 2026 at 02:26 PM UTC
Issuer: Bloomberg (5493001KJTIIGC8Y1R12)
Registered with: Financial Supervisory Commission (FSC) (RA001009)
Identifier: 38600433
Verified against: Financial Supervisory Commission (FSC) (RA001009)
Verified as: 38600433
Corroboration: Confirmed against a public register
GLEIF conformity: Meets the standard

Corporate structure

Owned by

台新證券投資信託股份有限公司
Fund managerTaiwan2549009G71CEPP44P173

Why no parent is reported

No direct parent reportedNo ultimate parent reported: No parent prepares consolidated accounts including it

Machine access

REST: https://lei.online/v1/entities/2549007LB0S56Y7VLO54This record as JSON.
MCP: https://lei.online/mcpThe same data as an MCP tool.

Start a new search